Pediatrics News

Children with ADHD, autism and other comorbid neurodevelopmental diagnoses who had well-controlled ADHD medication use for 1 year had improved cognitive test scores and ADHD symptoms, according to a Journal of Psychiatric Research study.

Suicidal ideation in early adolescence predicted other symptoms of depression, while depressive symptoms in middle adolescence predicted suicidal ideation, according to a study in Journal of Psychiatric Research.

Researchers reported that prenatal use of antipsychotics was not associated with risks for adverse outcomes in children — specifically, ADHD, autism spectrum disorder, preterm birth or being born small for gestational age.

Most adolescents in a cohort study conducted in Norway coped well during the COVID-19 pandemic, but intervention strategies may need to identify youth disproportionately affected by anxieties related to the pandemic, researchers noted.

The global prevalence of symptoms of clinically elevated depression and anxiety has likely doubled among children during the COVID-19 pandemic, researchers reported in JAMA Pediatrics.

Youth psychotherapy interventions with majority-Black samples were significantly less effective among communities with higher anti-Black cultural racism, according to results of a meta-analysis.

Maternal smoking during pregnancy may increase risk for conduct disorder symptoms among offspring, according to study results published in Journal of Psychiatric Research.

The assumption that half of childhood ADHD cases remit by adulthood may be inaccurate, as symptoms fluctuate into adulthood in most cases, according to results of a multimodal treatment study published in American Journal of Psychiatry.

Preterm and early term birth were associated with a significantly increased risk for autism spectrum disorder in both boys and girls in a study that included more than 4 million children born over a 40-year period in Sweden.

A stepped-care cognitive behavioral therapy model was cost-effective for children and adolescents with obsessive-compulsive disorder, according to an economic evaluation of a randomized noninferiority trial published in JAMA Network Open.